Transforming Mind Solutions shares an interest in research and development. Alex and Leigh from Smart TMS work together to make sure all our patients are receiving the latest protocols and sharing the most up to date research. Transforming Mind Solutions are happy to work in partnership with Smart TMS.
Magstim are the market leader in research and development for Neurological conditions. They manufacture the most up to date equipment that allows clinics like ours to be able to offer you the very highest standard of treatments. Magstim supply our machine which is a neuro navigator highest spec machine for TMS.
Our treatment finance company, allows us to be able to offer you the best treatment combined with affordable payments. They get our business and will get you when it comes to making sure you receive the best treatment when applying for their finance.
With our Sooma therapies, we want to provide an effective and safe way to treat disorders within psychiatry and neurology. We want to offer a safe, drug-free treatment option with minimal side effects, that minimises any discomfort that might otherwise come with treating certain disorders.
If you’re living with mental illness, you’ll know that the correct treatment and medication makes all the difference. And getting the most effective treatment and medication has never been more important.
That’s why this genetic test has been designed to help your doctor quickly make the right treatment decisions for you.
If you’ve taken two or more oral antidepressants and still experience symptoms of depression, you might have treatment-resistant depression(TRD).
It might be time to talk to your doctor about a different treatment approach. See what makes SPRAVATO® different
Working withTransforming Mind Solutions tranquil TMS who are based in Cheadle, they offer depression treatment to clients throughout Cheshire, Liverpool and Manchester areas.
Transforming Mind Solutions collaborates closely with Flow Neuroscience, offering the option to purchase or rent Flow tDCS headsets.With an impressive 77% of users experiencing clinical improvement within just three weeks.